# The improvement effect and mechanism of traditional Chinese medicine on chemotherapy-induced diarrhea: a systematic review

**Authors:** Yuzheng Wu, Xiaoyan Cao, Lequan Yu, Jingchun Yao, Chenghong Sun, Jingya Ruan, Dan Wang, Yi Zhang, Tao Wang

PMC · DOI: 10.3389/fphar.2025.1648107 · Frontiers in Pharmacology · 2026-01-07

## TL;DR

This review explores how traditional Chinese medicine can help reduce chemotherapy-induced diarrhea in cancer patients, offering a safer and effective alternative.

## Contribution

The paper systematically reviews TCM's mechanisms and effectiveness in treating chemotherapy-induced diarrhea, highlighting multiple pathways involved.

## Key findings

- TCM shows favorable curative outcomes and safety in treating chemotherapy-induced diarrhea.
- Mechanisms include antioxidant, anti-inflammatory, and regulation of intestinal flora effects.
- Key pathways involved are Keap1/Nrf2, TLR4/NLRP3, and JAK2/STAT3.

## Abstract

Chemotherapy-induced diarrhea (CID) is one of the gastrointestinal adverse effects in cancer patients after chemotherapy, which seriously affects the course of chemotherapy and reduces the survival rate of patients. The medications commonly used to improve CID include loperamide and octreotide. However, the use of these drugs is often accompanied by adverse effects. Currently, extensive preclinical and clinical studies have demonstrated that specific Traditional Chinese Medicine (TCM) formulations and their active metabolites can effectively alleviate CID. Meanwhile, it has been verified that TCM demonstrates favorable curative outcomes and satisfactory safety, which provides a new alternative for patients suffering from this condition. In this review, we focus on the recent studies in which TCM were applied to treat CID both in animal models and patients, and summarize the mechanism of TCM in improving CID from the aspects of antioxidant, anti-inflammation, maintenance of intestinal mucosal barrier and regulation of intestinal flora. We found that TCM has a definite therapeutic effect in the treatment of CID, which reflected in multiple levels and multiple pathways, including Keap1/Nrf2, TLR4/NLRP3, TLR4/NF-κB, JAK2/STAT3, Wnt, AKT, and MAPK. The aim of this review was to provide some references for applying TCM to treat CID in clinic, and provide new insights into the critical path ahead of the development of innovative drugs in alleviating CID.

## Linked entities

- **Genes:** KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], TLR4 (toll like receptor 4) [NCBI Gene 7099], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], JAK2 (Janus kinase 2) [NCBI Gene 3717], STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774], Wnt (protein Wnt-2) [NCBI Gene 100641115], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], MAPK (mitogen activated kinase-like protein) [NCBI Gene 7446652]
- **Chemicals:** loperamide (PubChem CID 3955), octreotide (PubChem CID 448601)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817] {aka INrf2, KLHL19}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}
- **Diseases:** inflammation (MESH:D007249), CID (MESH:D000084202), gastrointestinal adverse effects (MESH:D005767), cancer (MESH:D009369)
- **Chemicals:** loperamide (MESH:D008139), octreotide (MESH:D015282)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12819682/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12819682/full.md

## References

105 references — full list in the complete paper: https://tomesphere.com/paper/PMC12819682/full.md

---
Source: https://tomesphere.com/paper/PMC12819682